Overview

Asia-Pacific Advanced Wound Care Market is poised to value over USD 4 billion by 2027 end at a CAGR of over 10.2% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Asia-Pacific Advanced Wound Care Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Asia-Pacific Advanced Wound Care Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Asia-Pacific Advanced Wound Care Market:
• 3M Company
• Smith & Nephew plc
• Coloplast A/S
• Medtronic plc
• Acelity L.P. Inc.
• Cardinal Health, Inc.
• ConvaTec Group Plc
• Essity Aktiebolag (BSN Medical GmbH)
• B. Braun Melsungen AG
• Mölnlycke Health Care AB.
• Hollister Incorporated
• Medline Industries, Inc.
• Johnson & Johnson
• Baxter International
• Triage Meditech
• Integra Lifesciences
(Note: The list of the major players will be updated with the latest market scenario and trends)

Asia-Pacific Advanced Wound Care Market Segmentation:
By Product
• Infection Management
  o Silver Wound Dressing
  o Non-silver Dressing
  o Collagen
• Exudate Management
  o Hydrocolloid
  o Foam Dressing
  o Alginate
  o Hydrogel
• Active Wound Care
  o Skin Substitute
  o Growth Factor
• Therapy Device
  o Negative Pressure Wound Therapy
  o Oxygen and Hyperbaric Oxygen Equipment
  o Electromagnetic Therapy Device
  o Others

By Application  
• Chronic Wound Care
  o Pressure Ulcer
  o Diabetic Foot Ulcer
  o Venous Leg Ulcer
  o Arterial Ulcer
• Acute Wound Care
  o Burns & Trauma
  o Surgical Wound

By End User
• Hospital
• Community Health Service Centers

By Region
• Japan
• China
• India
• Australia and New Zealand
• ASEAN
• Rest of Asia Pacific

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Asia-Pacific Advanced Wound Care Market By Product, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Japan, China, India, Australia And New Zealand, ASEAN, Rest Of Asia Pacific
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Asia-Pacific Advanced Wound Care Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Asia-Pacific Advanced Wound Care Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Asia-Pacific Advanced Wound Care Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Asia-Pacific Advanced Wound Care Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Infection Management
       7.1.1. Silver Wound Dressing
       7.1.2. Non-silver Dressing
       7.1.3. Collagen
  7.2. Exudate Management
       7.2.1. Hydrocolloid
       7.2.2. Foam Dressing
       7.2.3. Alginate
       7.2.4. Hydrogel
  7.3. Active Wound Care
       7.3.1. Skin Substitute
       7.3.2. Growth Factor
  7.4. Therapy Device
       7.4.1. Negative Pressure Wound Therapy
       7.4.2. Oxygen and Hyperbaric Oxygen Equipment
       7.4.3. Electromagnetic Therapy Device
       7.4.4. Others

8. Asia-Pacific Advanced Wound Care Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
  8.1. Chronic Wound Care
       8.1.1. Pressure Ulcer
       8.1.2. Diabetic Foot Ulcer
       8.1.3. Venous Leg Ulcer
       8.1.4. Arterial Ulcer
  8.2. Wound Care
       8.2.1. Burns & Trauma
       8.2.2. Surgical Wound

9. Asia-Pacific Advanced Wound Care Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)  
  9.1. Hospital
  9.2. Community Health Service Centers

10. Asia Pacific Advanced Wound Care Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         10.2.1. Japan
         10.2.2. China
         10.2.3. India
         10.2.4. Australia and New Zealand
         10.2.5. ASEAN
         10.2.6. Rest of Asia Pacific
   10.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

11. Market Share Analysis and Competitive Landscape  
   11.1. Asia Pacific Landscape - Key Players, Revenue and Presence
   11.2. Asia Pacific Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   11.3. Asia Pacific Emerging Companies
   11.4. Asia Pacific - Market Share Analysis and Key Regional Players
   11.5. Asia Pacific Key Player - Growth Matrix

12. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   12.1. 3M Company
         12.1.1. Company Overview
         12.1.2. Product Portfolio
         12.1.3. SWOT Analysis
         12.1.4. Financial Overview
         12.1.5. Strategic Overview
   12.2. Smith & Nephew plc
         12.2.1. Company Overview
         12.2.2. Product Portfolio
         12.2.3. SWOT Analysis
         12.2.4. Financial Overview
         12.2.5. Strategic Overview
   12.3. Coloplast A/S
         12.3.1. Company Overview
         12.3.2. Product Portfolio
         12.3.3. SWOT Analysis
         12.3.4. Financial Overview
         12.3.5. Strategic Overview
   12.4. Medtronic plc
         12.4.1. Company Overview
         12.4.2. Product Portfolio
         12.4.3. SWOT Analysis
         12.4.4. Financial Overview
         12.4.5. Strategic Overview
   12.5. Acelity L.P. Inc.
         12.5.1. Company Overview
         12.5.2. Product Portfolio
         12.5.3. SWOT Analysis
         12.5.4. Financial Overview
         12.5.5. Strategic Overview          
   12.6. Cardinal Health, Inc.
         12.6.1. Company Overview
         12.6.2. Product Portfolio
         12.6.3. SWOT Analysis
         12.6.4. Financial Overview
         12.6.5. Strategic Overview      
   12.7. ConvaTec Group Plc
         12.7.1. Company Overview
         12.7.2. Product Portfolio
         12.7.3. SWOT Analysis
         12.7.4. Financial Overview
         12.7.5. Strategic Overview
   12.8. Essity Aktiebolag (BSN Medical GmbH)
         12.8.1. Company Overview
         12.8.2. Product Portfolio
         12.8.3. SWOT Analysis
         12.8.4. Financial Overview
         12.8.5. Strategic Overview
   12.9. B. Braun Melsungen AG
         12.9.1. Company Overview
         12.9.2. Product Portfolio
         12.9.3. SWOT Analysis
         12.9.4. Financial Overview
         12.9.5. Strategic Overview
   12.10.Mölnlycke Health Care AB.
         12.10.1. Company Overview
         12.10.2. Product Portfolio
         12.10.3. SWOT Analysis
         12.10.4. Financial Overview
         12.10.5. Strategic Overview
   12.11.Hollister Incorporated
         12.11.1. Company Overview
         12.11.2. Product Portfolio
         12.11.3. SWOT Analysis
         12.11.4. Financial Overview
         12.11.5. Strategic Overview
   12.12.Medline Industries, Inc.
         12.12.1. Company Overview
         12.12.2. Product Portfolio
         12.12.3. SWOT Analysis
         12.12.4. Financial Overview
         12.12.5. Strategic Overview
   12.13.Johnson & Johnson
         12.13.1. Company Overview
         12.13.2. Product Portfolio
         12.13.3. SWOT Analysis
         12.13.4. Financial Overview
         12.13.5. Strategic Overview
   12.14.Baxter International
         12.14.1. Company Overview
         12.14.2. Product Portfolio
         12.14.3. SWOT Analysis
         12.14.4. Financial Overview
         12.14.5. Strategic Overview
   12.15.Triage Meditech
         12.15.1. Company Overview
         12.15.2. Product Portfolio
         12.15.3. SWOT Analysis
         12.15.4. Financial Overview
         12.15.5. Strategic Overview
   12.16.Integra Lifesciences
         12.16.1. Company Overview
         12.16.2. Product Portfolio
         12.16.3. SWOT Analysis
         12.16.4. Financial Overview
         12.16.5. Strategic Overview

13. Pre and Post COVID-19 Impact
   13.1. Positive influence on the healthcare industry
   13.2. The financial disruption of the manufacturing sector
   13.3. Impact of COVID-19 on emerging companies
   13.4. Significant mandates in the healthcare regulations initiated by administrations
   13.5. The overall economic slowdown of the developing and developed nations

14. FutureWise SME Key Takeaway Points for Client

Tables

Figures